S&P 및 Nasdaq 내재가치 문의하기

BrainsWay Ltd. BWAY NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • IL • USD

SharesGrow Score
68/100
2/7 Pass
SharesGrow Intrinsic Value
$14.70
-7%
Analyst Price Target
$30.00
+89.8%

BrainsWay Ltd. (BWAY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Jerusalem, Israel. 현재 CEO는 Hadar Levy.

BWAY 을(를) 보유 IPO 날짜 2019-04-17, 120 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $620.12M.

BrainsWay Ltd. 소개

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

📍 Bynet Building, Jerusalem 9777518 📞 972 2 582 4030
회사 세부정보
섹터헬스케어
산업Medical - Devices
국가Israel
거래소NASDAQ Global Market
통화USD
IPO 날짜2019-04-17
CEOHadar Levy
직원 수120
거래 정보
현재 가격$15.81
시가역액$620.12M
52주 범위3.92-14.65
베타1.20
ETF아니오
ADR
CUSIP10501L106
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기